Immediate Impact
3 from Science/Nature 49 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Mathieu Daynac being referenced
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
2016
The Human Papillomavirus E6 Oncogene Represses a Cell Adhesion Pathway and Disrupts Focal Adhesion through Degradation of TAp63β upon Transformation
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mathieu Daynac | 371 | 283 | 89 | 103 | 18 | 608 | |
| Cyrille Deboux | 271 | 313 | 81 | 136 | 20 | 604 | |
| C. Goujet‐Zalc | 343 | 250 | 35 | 63 | 22 | 573 | |
| Karine Magalon | 227 | 290 | 44 | 138 | 19 | 559 | |
| M. Raoul | 327 | 261 | 92 | 147 | 12 | 681 | |
| Carmen Ramírez‐Castillejo | 325 | 202 | 103 | 65 | 30 | 653 | |
| Paula Franco | 355 | 251 | 33 | 120 | 23 | 641 | |
| Danyang He | 331 | 171 | 48 | 173 | 15 | 699 | |
| Eva Porlan | 430 | 290 | 65 | 66 | 17 | 700 | |
| Brigitte Schultze | 228 | 193 | 36 | 72 | 25 | 653 | |
| W. Blakemore | 273 | 302 | 75 | 169 | 13 | 668 |
All Works
Login with ORCID to disown or claim papers
Loading papers...